Literature DB >> 24319778

Immunological functions of the neuropilins and plexins as receptors for semaphorins.

Atsushi Kumanogoh, Hitoshi Kikutani.   

Abstract

Semaphorins were originally identified as axon-guidance molecules that function during neuronal development. However, cumulative evidence indicates that semaphorins also participate in immune responses, both physiological and pathological, and they are now considered to be potential diagnostic and/or therapeutic targets for a range of diseases. The primary receptors for semaphorins are neuropilins and plexins, which have cell type-specific patterns of expression and are involved in multiple signalling responses. In this Review, we focus on the roles of neuropilin 1 (NRP1) and plexins in the regulation of the immune system, and we summarize recent advances in our understanding of their pathological implications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24319778     DOI: 10.1038/nri3545

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  129 in total

1.  Unified nomenclature for the semaphorins/collapsins. Semaphorin Nomenclature Committee.

Authors: 
Journal:  Cell       Date:  1999-05-28       Impact factor: 41.582

2.  Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling.

Authors:  Boaz Kigel; Noa Rabinowicz; Asya Varshavsky; Ofra Kessler; Gera Neufeld
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

Review 3.  Plasmacytoid dendritic cells: recent progress and open questions.

Authors:  Boris Reizis; Anna Bunin; Hiyaa S Ghosh; Kanako L Lewis; Vanja Sisirak
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

4.  Semaphorin 7A is a negative regulator of T cell responses.

Authors:  Agnieszka K Czopik; Margaret S Bynoe; Noah Palm; Cedric S Raine; Ruslan Medzhitov
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

5.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

6.  An inhibitory role for Sema4A in antigen-specific allergic asthma.

Authors:  Tetsuo Morihana; Sho Goya; Masayuki Mizui; Teruhito Yasui; Durubaka V R Prasad; Atsushi Kumanogoh; Manabu Tamura; Takashi Shikina; Yohei Maeda; Yoriko Iwamoto; Hidenori Inohara; Hitoshi Kikutani
Journal:  J Clin Immunol       Date:  2012-09-25       Impact factor: 8.317

7.  Site-directed mutagenesis in the B-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F.

Authors:  Elena Geretti; Akio Shimizu; Peter Kurschat; Michael Klagsbrun
Journal:  J Biol Chem       Date:  2007-06-26       Impact factor: 5.157

8.  Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse.

Authors:  F Nakamura; M Tanaka; T Takahashi; R G Kalb; S M Strittmatter
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

Review 9.  Function of members of the neuropilin family as essential pleiotropic cell surface receptors.

Authors:  Matthew W Parker; Hou-Fu Guo; Xiaobo Li; Andrew D Linkugel; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

10.  Sema3a maintains normal heart rhythm through sympathetic innervation patterning.

Authors:  Masaki Ieda; Hideaki Kanazawa; Kensuke Kimura; Fumiyuki Hattori; Yasuyo Ieda; Masahiko Taniguchi; Jong-Kook Lee; Keisuke Matsumura; Yuichi Tomita; Shunichiro Miyoshi; Kouji Shimoda; Shinji Makino; Motoaki Sano; Itsuo Kodama; Satoshi Ogawa; Keiichi Fukuda
Journal:  Nat Med       Date:  2007-04-08       Impact factor: 53.440

View more
  73 in total

1.  Netrin-1 Augments Chemokinesis in CD4+ T Cells In Vitro and Elicits a Proinflammatory Response In Vivo.

Authors:  Leo Boneschansker; Hironao Nakayama; Michele Eisenga; Johannes Wedel; Michael Klagsbrun; Daniel Irimia; David M Briscoe
Journal:  J Immunol       Date:  2016-07-18       Impact factor: 5.422

Review 2.  Regulation of dendritic development by semaphorin 3A through novel intracellular remote signaling.

Authors:  Yoshio Goshima; Naoya Yamashita; Fumio Nakamura; Yukio Sasaki
Journal:  Cell Adh Migr       Date:  2016-07-08       Impact factor: 3.405

Review 3.  Axon formation, extension, and navigation: only a neuroscience phenomenon?

Authors:  Shannon K Rich; Jonathan R Terman
Journal:  Curr Opin Neurobiol       Date:  2018-09-21       Impact factor: 6.627

Review 4.  Divergent roles of Plexin D1 in cancer.

Authors:  Sneha Vivekanadhan; Debabrata Mukhopadhyay
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

5.  Class 3 semaphorins induce F-actin reorganization in human dendritic cells: Role in cell migration.

Authors:  Sabrina Curreli; Bin Sheng Wong; Olga Latinovic; Konstantinos Konstantopoulos; Nicholas M Stamatos
Journal:  J Leukoc Biol       Date:  2016-07-12       Impact factor: 4.962

Review 6.  Semaphorins and plexins as therapeutic targets.

Authors:  Thomas Worzfeld; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2014-08       Impact factor: 84.694

7.  Regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by semaphorin 3A.

Authors:  Ethan M Lotz; Michael B Berger; Barbara D Boyan; Zvi Schwartz
Journal:  Bone       Date:  2020-02-03       Impact factor: 4.398

Review 8.  The role of semaphorins in immune responses and autoimmune rheumatic diseases.

Authors:  Masayuki Nishide; Atsushi Kumanogoh
Journal:  Nat Rev Rheumatol       Date:  2017-12-07       Impact factor: 20.543

Review 9.  Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases.

Authors:  Na Wei; Qian Zhang; Xiang-Lei Yang
Journal:  J Biol Chem       Date:  2019-01-14       Impact factor: 5.157

Review 10.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.